TABLE 2.
Sample collection time | RT-qPCR test | N501Y | D614G | ORF1abb | RNase P gene |
---|---|---|---|---|---|
January 2021 | Positive | 0 | 58 | 132 | 139 |
Total (N) | 139 | 139 | 139 | 139 | |
Alpha variant detection rate (%) | 0 | 41.7 | 95.0 | 100.0 | |
February 2021 | Positive | 7 | 78 | 139 | 139 |
Total | 139 | 139 | 139 | 139 | |
Alpha variant detection rate (%) | 5.0 | 56.1 | 100.0 | 100.0 | |
March 2021 | Positive | 10 | 41 | 96 | 96 |
Total | 96 | 96 | 96 | 96 | |
Alpha variant detection rate (%) | 10.4 | 42.7 | 100.0 | 100.0 |
Three hundred seventy-four clinical samples collected in middle January, late February, and March 2021 in the California Bay area.
ORF1ab gene was targeted for wild-type SARS-CoV-2.